DIADIA0.27%
SPYSPY0.19%
QQQQQQ0.45%
Trending
Top trending tickerBTCBTC4.13%
MRVLMRVL29.52%
MSTRMSTR7.93%
HPEHPE17.38%
SMRSMR9.78%
ETHETH1.76%
BMNRBMNR5.15%
CMGCMG4.32%
ABVXABVX44.21%
XRPXRP4.10%
Top trending tickerBTCBTC4.13%
MRVLMRVL29.52%
MSTRMSTR7.93%
HPEHPE17.38%
SMRSMR9.78%
ETHETH1.76%
BMNRBMNR5.15%
CMGCMG4.32%
ABVXABVX44.21%
XRPXRP4.10%
VOR logo

VORVor Biopharma Inc

$14.11
$0.46
(3.16%)
Today
Updated: 12:16 PM EDT
EarningsAug 14
Mkt Cap$789.49M
Vol326,674.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

News
all
press releases
Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade
The consensus price target hints at a 124.6% upside potential for Vor Biopharma (VOR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
News Placeholder
More News
News Placeholder
Jefferies Financial Group Upgrades Vor Biopharma (NASDAQ:VOR) to Strong-Buy
Jefferies Financial Group upgraded shares of Vor Biopharma to a "strong-buy" rating in a report on Thursday...
MarketBeat
News Placeholder
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Moderate Buy" from Brokerages
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the thirteen analysts that are presently covering the stock, Marketbeat reports. One...
MarketBeat
News Placeholder
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Down 17.3% in April
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totaling 4,706,707 shares, a...
MarketBeat
News Placeholder
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 165,150 Shares
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) Director Ra Capital Management, L.P. sold 165,150 shares of the business's stock in a transaction dated Wednesday, April 22nd. The stock was sold at an average price of $15.77, for a total value of $2,604,415.50. Following the sale, the director...
MarketBeat
News Placeholder
Vor Biopharma (NASDAQ:VOR) Director Sells $2,711,856.51 in Stock
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) Director Ra Capital Management, L.P. sold 171,963 shares of the stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price of $15.77, for a total transaction of $2,711,856.51. Following the sale, the...
MarketBeat
News Placeholder
Vor Biopharma (NASDAQ:VOR) Director Sells $7,462,931.08 in Stock
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) Director Ra Capital Management, L.P. sold 458,411 shares of the firm's stock in a transaction that occurred on Friday, April 17th. The shares were...
MarketBeat
News Placeholder
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 171,963 Shares of Stock
Vor Biopharma Inc. (NASDAQ:VOR - Get Free Report) Director Ra Capital Management, L.P. sold 171,963 shares of the company's stock in a transaction dated Monday, April 20th. The stock was sold at an...
MarketBeat
News Placeholder
Vor Biopharma (NASDAQ:VOR) Shares Down 4.4% - Here's What Happened
Vor Biopharma (NASDAQ:VOR) Shares Down 4.4% - Here's What Happened...
MarketBeat
News Placeholder
Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 117% in Vor Biopharma (VOR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
<
1
2
...
>
Top Discussions

Advertisement|Remove ads.